Dr. Byrne is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
200 Hawkins Dr
Iowa City, IA 52242Phone+1 319-356-5346Fax+1 319-353-8383
Education & Training
University of North Carolina HospitalsResidency, Internal Medicine, 2011 - 2014
Rush Medical College of Rush University Medical CenterClass of 2011
Certifications & Licensure
IA State Medical License 2021 - 2025
MA State Medical License 2017 - 2022
NC State Medical License 2011 - 2017- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- Phase II study of nab-paclitaxel with gemcitabine for relapsed/refractory small cell lung cancer.Margaret M Byrne, Grerk Sutamtewagul, William Zeitler, Sarah L Mott, Gideon K D Zamba
Frontiers in Oncology. 2024-01-01 - 12 citationsInflammation as a Therapeutic Target in Cancer Cachexia.Gerald Clamon, Margaret M Byrne, Erin E Talbert
Cancers. 2022-10-26 - 16 citationsPharmacological ascorbate improves the response to platinum-based chemotherapy in advanced stage non-small cell lung cancer.Muhammad Furqan, Taher Abu-Hejleh, Laura M Stephens, Stacey M Hartwig, Sarah L Mott
Redox Biology. 2022-07-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
